Short setupTrying out my first elliot count. Also put a few rising wedges in there. I can't imagine the fundamentals that will bring AZN into such a deep correction though.Trying out my first elliot count. Also put a few rising wedges in there. I can't imagine the fundamentals that will bring AZN into such a deep correction though.Shortby wahlwestUpdated 5
AZN AstraZeneca PLC Options Ahead of EarningsAnalyzing the options chain and the chart patterns of AZN AstraZeneca PLC prior to the earnings report this week, I would consider purchasing the 66usd strike price in the money Puts with an expiration date of 2023-11-10, for a premium of approximately $2.30. If these options prove to be profitable Analyzing the options chain and the chart patterns of AZN AstraZeneca PLC prior to the earnings report this week, I would consider purchasing the 66usd strike price in the money Puts with an expiration date of 2023-11-10, for a premium of approximately $2.30. If these options prove to be profitable Shortby TopgOptionsUpdated 1
AZN Starting A Long Journey UpDaily Chart of AZN AZN bounced from an important support level. Waves 1 and 2 are complete. Wave 2 ended with a long pin bar. This means that the support level is strong. Volume has also picked up. AZN to go up to 75. Daily Chart of AZN AZN bounced from an important support level. Waves 1 and 2 are complete. Wave 2 ended with a long pin bar. This means that the support level is strong. Volume has also picked up. AZN to go up to 75. Longby RS31750
Short AgainWe are seeing an upward correction and have reached the MA and the top from 2 days ago again. The momentum is declining. That's clear - it is a correction. But as we are in a downtrend since August the preferred direction remains downward. We are seeing an upward correction and have reached the MA and the top from 2 days ago again. The momentum is declining. That's clear - it is a correction. But as we are in a downtrend since August the preferred direction remains downward. Shortby motleifaulUpdated 1
Resisting HereWe are currently trading within a broader range. However, now we are approaching the important MA which is also the 50% retracement of the decline since August. As the window which had been opened on Monday has been closed now as well I can assume that the test of the high built on September 15th wiWe are currently trading within a broader range. However, now we are approaching the important MA which is also the 50% retracement of the decline since August. As the window which had been opened on Monday has been closed now as well I can assume that the test of the high built on September 15th wiShortby motleifaulUpdated 0
AZN - BEARISH SCENARIOAstraZeneca's stock experienced a significant decline of over 4% on Monday due to uncertainties surrounding the future of CEO Pascal Soriot, as reported in the news. Initially, the company refrained from commenting on the report but later clarified that they do not engage in discussions regarding maAstraZeneca's stock experienced a significant decline of over 4% on Monday due to uncertainties surrounding the future of CEO Pascal Soriot, as reported in the news. Initially, the company refrained from commenting on the report but later clarified that they do not engage in discussions regarding maShortby legacyFXofficial111
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NASDAQ:AZN after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 85.71%.The PEAD projected a bullish outlook for NASDAQ:AZN after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 85.71%.Longby EPSMomentum1
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NASDAQ:AZN after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 80%.The PEAD projected a bullish outlook for NASDAQ:AZN after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 80%.Longby EPSMomentum1
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for $AZN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 83.33%.The PEAD projected a bullish outlook for $AZN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 83.33%.Longby EPSMomentum0
AZN To Test Yearly Pivot Support AstraZeneca marginally eclipsed its prior cycle highs through the 72.00 level before pulling back to suggest a potential weekly double top pattern, however, I would highlight the lack of momentum divergence at this point, which suggests to me that the current retreat is corrective. On the four-hour AstraZeneca marginally eclipsed its prior cycle highs through the 72.00 level before pulling back to suggest a potential weekly double top pattern, however, I would highlight the lack of momentum divergence at this point, which suggests to me that the current retreat is corrective. On the four-hour 02:17by Tickmill3